Your Sorted CME/CE Activities

Quarterly Brief (January-March, 2019): A Current Expert Analysis on Important HIV Clinical Decisions
Certified CME/CNE/CPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from January through March, 2019, will discuss HIV treatment, complications/side effect management and prevention strategies.

Review the Quarterly Brief and claim AMA, ANCC, or ACPE credit/contact hour(s) after completion of the brief Post-Test/Evaluation.








Ask the Expert
Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical Center
Faculty
Jared Baeten, MD, PhD Jared Baeten, MD, PhD
Professor and Vice Chair
University of Washington
Seattle, Washington
Kristine M. Erlandson, MD, MS Kristine M. Erlandson, MD, MS
Associate Professor of Medicine
University of Colorado – Anschutz Medical Campus
Aurora, Colorado

20
Supported by an independent educational grant from ViiV Healthcare.
March 31, 2020
Mini Module
6300
QuarterlyBrief_WebBanner_1158.gif
HIV